GUJARAT THEMIS BIOSYN
|
The Current P/S Ratio of GUJARAT THEMIS BIOSYN is 25.07.
| Share Price | ₹381.4 | Jun 17,2026 |
| Market Cap | ₹4,156.7 Cr | |
| Sales-TTM | ₹165.8 Cr | TTM-Standalone Results |
| Price/Sales | 25.07x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GUJARAT THEMIS BIOSYN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,156.7 Cr] as on Jun 17,2026
(/) Sales [ ₹165.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 25.07x ]
Thus, for GUJARAT THEMIS BIOSYN , the investors are currently willing to pay '25.07 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GUJARAT THEMIS BIOSYN !
The chart below summarizes the trend in P/S Ratio of GUJARAT THEMIS BIOSYN over the last five years.
Historical PS (Price/Sales) ratio chart of GUJARAT THEMIS BIOSYN
PS Ratio Performance Analysis for GUJARAT THEMIS BIOSYN
- GUJARAT THEMIS BIOSYN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 10.48x.
- GUJARAT THEMIS BIOSYN 's operated at median p/e ratio of 6.72x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GUJARAT THEMIS BIOSYN 's p/e ratio peaked in Mar2025 at 20.34x.
- GUJARAT THEMIS BIOSYN 's p/e ratio hit its five-year low in Mar2021 of 3.27x.
How does GUJARAT THEMIS BIOSYN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GUJARAT THEMIS BIOSYN | 165.8 | 25.07 | 4,156.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.47 | 436,667.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.74 | 176,805.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.77 | 150,554.0 |
| CIPLA LTD | 28,162.6 | 3.87 | 109,120.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.14 | 105,920.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.84 | 97,611.6 |
| LUPIN LTD | 27,958.0 | 3.71 | 103,645.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.93 | 106,812.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.43 | 81,824.5 |
| LAURUS LABS LTD | 6,812.9 | 10.86 | 73,957.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GUJARAT THEMIS BIOSYN 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.43x |
| Max industry PS | 25.07x |
| Median industry PS | 6.84x |
| Average industry PS | 8.62x |
You may also like the below Video Courses